Oncolytics Biotech (ONCY)
(Delayed Data from NSDQ)
$1.25 USD
+0.01 (0.81%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/1/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | 12.50% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.29 |
Next Year | -0.32 |
EPS (TTM) | -0.28 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.06 | -0.29 | -0.32 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.08 | -0.04 | -0.28 | -0.33 |
High Estimate | -0.07 | -0.04 | -0.28 | -0.30 |
Low Estimate | -0.08 | -0.07 | -0.30 | -0.33 |
Year ago EPS | -0.10 | -0.04 | -0.30 | -0.29 |
Year over Year Growth Est. | 20.00% | -50.00% | 3.33% | -9.23% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.06 | -0.29 | -0.32 |
7 Days Ago | -0.08 | -0.06 | -0.29 | -0.32 |
30 Days Ago | -0.08 | -0.06 | -0.29 | -0.32 |
60 Days Ago | -0.08 | -0.06 | -0.29 | -0.32 |
90 Days Ago | -0.08 | -0.06 | -0.29 | -0.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.06 | -0.29 | -0.33 |
Zacks Consensus Estimate | -0.08 | -0.06 | -0.29 | -0.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -4.76% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.07 | -0.04 | -0.10 | NA |
Estimate | -0.08 | -0.09 | -0.11 | -0.07 | NA |
Difference | 0.01 | 0.02 | 0.07 | -0.03 | 0.02 |
Surprise | 12.50% | 22.22% | 63.64% | -42.86% | 13.88% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more